Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€42.57
03.06.22
-
03.06.23
-9.55%
11.06.22

Risky Investment
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€4.81
14.03.22
€6.40
14.03.23
-33.68%
11.06.22

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€49.15
01.06.22
-
01.06.23
-2.34%
11.06.22

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.19
30.05.22
-
30.05.23
-7.79%
11.06.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€22.29
29.05.22
-
29.05.23
-0.67%
09.06.22

Could be very worthwhile Investment >20% year
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€4.75
11.04.22
-
11.04.23
-41.07%
08.06.22

Could be worthwhile Investment >10% per year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€114.10
07.01.22
€130.00
07.01.23
-63.63%
05.06.22

Could be worthwhile Investment >10% per year
buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.74
31.05.21
€15.00
31.05.22
-60.61%
01.06.22

Fair valuation
Strong uniques
Leading role in innovation
Bad rating
buy
Adverum Biotechnologies Inc.

Start price
Target price
Perf. (%)
€2.86
29.05.21
-
29.05.22
-71.59%
30.05.22

Could be very worthwhile Investment >20% year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€1.18
15.05.22
-
15.05.23
-19.25%
29.05.22

Could be very worthwhile Investment >20% year
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€28.60
16.05.22
-
16.05.23
-14.58%
28.05.22

Risky Investment
Concert Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.44
17.10.21
-
17.10.22
121.23%
28.05.22

Could be worthwhile Investment >10% per year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.08
18.05.22
-
18.05.23
10.77%
28.05.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Chimerix Inc.

Start price
Target price
Perf. (%)
€2.60
16.05.22
€3.00
16.05.23
-28.60%
28.05.22

Could be worthwhile Investment >10% per year
Capable Management
Little innovation
Novavax Inc.

Start price
Target price
Perf. (%)
€42.61
25.05.22
€40.00
25.05.23
21.57%
27.05.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€75.60
26.05.21
€82.00
26.05.22
-36.11%
27.05.22

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€55.10
03.05.22
€60.00
03.05.23
-22.67%
25.05.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Chimerix Inc.

Start price
Target price
Perf. (%)
€2.00
19.05.22
-
19.05.23
-11.40%
24.05.22

Probably not worthwhile Investment
buy
Agenus Inc.

Start price
Target price
Perf. (%)
€2.54
22.03.22
-
22.03.23
-42.13%
21.05.22

buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€16.50
08.07.21
-
08.07.22
-80.73%
21.05.22

buy
Pieris Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€2.94
08.07.21
-
08.07.22
-43.91%
21.05.22

buy
Magenta Therapeutics

Start price
Target price
Perf. (%)
€7.98
08.07.21
-
08.07.22
-85.96%
21.05.22

buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€71.40
08.07.21
-
08.07.22
-69.54%
21.05.22

buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.42
08.07.21
-
08.07.22
-55.26%
21.05.22

buy
Affimed N.V.

Start price
Target price
Perf. (%)
€5.91
08.07.21
-
08.07.22
-43.41%
21.05.22